Canada Diabetes Care Devices Market Size

Statistics for the 2023 & 2024 Canada Diabetes Care Devices market size, created by Mordor Intelligence™ Industry Reports. Canada Diabetes Care Devices size report includes a market forecast to 029) and historical overview. Get a sample of this industry size analysis as a free report PDF download.

Market Size of Canada Diabetes Care Devices Industry

Canada Diabetes Devices Market Summary
Study Period 2018 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 1.93 Billion
Market Size (2029) USD 2.47 Billion
CAGR (2024 - 2029) 4.98 %

Major Players

Canada Diabetes Care Devices Market  Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Canada Diabetes Care Devices Market Analysis

The Canada Diabetes Care Devices Market size is estimated at USD 1.93 billion in 2024, and is expected to reach USD 2.47 billion by 2029, growing at a CAGR of 4.98% during the forecast period (2024-2029).

Canada has 107,861 cases of coronavirus disease 2019 (COVID-19) (286 per 1,00,000 individuals) and 8787 COVID-19-related fatalities as of July 13, 2020. In Canada, public health is overseen at the federal, provincial, and regional levels, and the Canadian constitution delegates healthcare authority to the country's ten provinces and three territories. As a result, similar to the United States, where individual states generally defined the COVID-19 response, Canadian provinces have mostly selected containment and mitigation plans. Provincial public health authorities collaborated closely with regional public health officers and municipal governments to develop policies and recommendations, as well as to put services like testing and contact tracing in place. Blood pressure regulation is a critical component of diabetes management. Furthermore, even in the absence of high blood pressure, certain blood pressure lowering medications are frequently recommended for people living with diabetes to protect them from kidney and heart-related complications. There is currently no scientific evidence linking these blood pressure drugs to the likelihood of COVID-19 infection or associated consequences.

In Canada, During the pandemic, many healthcare providers have adopted a hybrid model of care, offering certain types of visits in-person at the clinic and others virtually, by phone, video chat, or secure messaging. Virtual diabetes care may be a new and different experience for you. For tips on preparing for your diabetes visit and managing virtual appointments.

Canada Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)